Beam Therapeutics Inc.

Historical 13F Holders

Symbol: BEAM
CUSIP: 07373V105
All holders as of: Q2 2026
Type: Equity
Class: COM

Reported Value, Excluding Options

Total Shares Held, Excluding Options

Total Filers

13D/G Filers

Each filer's latest filing for 07373V105 since 12/18/2024, largest first.

Filer	% of Class	Shares	Form	Filed
FMR LLC 13G/A	12.6%	12,750,369.42	13G/A	2/5/2026 Event 12/31/2025
FMR LLC	12.6%	12,750,369.42
Abigail P. Johnson	12.6%	12,750,369.42
Farallon Capital Management, L.L.C. 13G/A	10.0%	10,282,210	13G/A	8/13/2026 Event 6/30/2026
Farallon Capital Management, L.L.C.	10.0%	10,282,210
Farallon Capital Partners, L.P.	0%	0
Farallon Capital Institutional Partners, L.P.	0%	0
Farallon Capital Institutional Partners II, L.P.	0%	0
Farallon Capital Institutional Partners III, L.P.	0%	0
Four Crossings Institutional Partners V, L.P.	0%	0
Farallon Capital Offshore Investors II, L.P.	0%	0
Farallon Capital (AM) Investors, L.P.	0%	0
Farallon Capital F5 Master I, L.P.	0%	0
Farallon Healthcare Partners Master, L.P.	0%	0
Farallon Partners, L.L.C.	0%	0
Farallon Institutional (GP) V, L.L.C.	0%	0
Farallon F5 (GP), L.L.C.	0%	0
Farallon Healthcare Partners (GP), L.L.C.	0%	0
Dapice Joshua J.	10.0%	10,282,210
Dreyfuss, Philip D.	10.0%	10,282,210
Dunn Hannah E.	10.0%	10,282,210
Gehani, Varun N.	10.0%	10,282,210
Giauque, Nicolas	10.0%	10,282,210
Husen, Avner A.	10.0%	10,282,210
Kim, David T.	10.0%	10,282,210
Linn, Michael G.	10.0%	10,282,210
Luo Patrick (Cheng)	10.0%	10,282,210
Roberts, Jr., Thomas G.	10.0%	10,282,210
Saito Edric C.	10.0%	10,282,210
Short Daniel S.	10.0%	10,282,210
Spokes, Andrew J. M.	10.0%	10,282,210
Warren, John R.	10.0%	10,282,210
Wehrly, Mark C.	10.0%	10,282,210
Farallon Capital Partners, L.P. 13G/A	10.0%	10,141,856	13G/A	2/5/2026 Event 12/31/2025
Farallon Capital Partners, L.P.	0.7%	688,623
Farallon Capital Institutional Partners, L.P.	0.8%	836,691
Farallon Capital Institutional Partners II, L.P.	0.2%	233,233
Farallon Capital Institutional Partners III, L.P.	0.1%	104,266
Four Crossings Institutional Partners V, L.P.	0.1%	150,101
Farallon Capital Offshore Investors II, L.P.	1.6%	1,632,718
Farallon Capital (AM) Investors, L.P.	0.1%	94,237
Farallon Capital F5 Master I, L.P.	0.3%	333,253
Farallon Healthcare Partners Master, L.P.	6.0%	6,068,735
Farallon Partners, L.L.C.	9.7%	9,808,603
Farallon Institutional (GP) V, L.L.C.	0.1%	150,101
Farallon F5 (GP), L.L.C.	0.3%	333,253
Farallon Healthcare Partners (GP), L.L.C.	6.0%	6,068,735
Dapice Joshua J.	10.0%	10,141,856
Dreyfuss, Philip D.	10.0%	10,141,856
Dunn Hannah E.	10.0%	10,141,856
Fried, Richard B	0%	0
Gehani, Varun N.	10.0%	10,141,856
Giauque, Nicolas	10.0%	10,141,856
Husen, Avner A.	10.0%	10,141,856
Kim, David T.	10.0%	10,141,856
Linn, Michael G.	10.0%	10,141,856
Luo Patrick (Cheng)	10.0%	10,141,856
Patel, Rajiv A.	0%	0
Roberts, Jr., Thomas G.	10.0%	10,141,856
Saito Edric C.	10.0%	10,141,856
Seybold, William	0%	0
Short Daniel S.	10.0%	10,141,856
Spokes, Andrew J. M.	10.0%	10,141,856
Warren, John R.	10.0%	10,141,856
Wehrly, Mark C.	10.0%	10,141,856
ARK Investment Management LLC 13G/A	10.0%	10,234,862	13G/A	8/14/2026 Event 6/30/2026
ARK Investment Management LLC	10.0%	10,234,862
Catherine D. Wood	10.0%	10,234,862
BlackRock, Inc. 13G/A	7.5%	7,499,930	13G/A	4/17/2025 Event 3/31/2025
State Street Corp 13G	5.2%	5,228,529	13G	2/9/2026 Event 12/31/2025
Vanguard Capital Management LLC 13G	5.0%	5,122,475	13G	4/29/2026 Event 3/31/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (2)
ARCH Venture Fund IX, L.P. 13G/A	4.6%	4,600,747	13G/A	5/15/2025 Event 3/31/2025
ARCH Venture Fund IX, L.P.	4.5%	4,540,132
ARCH Venture Fund IX Overage, L.P.	4.5%	4,540,132
ARCH Venture Partners IX, L.P.	4.5%	4,540,132
ARCH Venture Partners IX Overage, L.P.	4.5%	4,540,132
ARCH Venture Partners IX, LLC	4.5%	4,540,132
Keith Crandell	4.5%	4,557,862
Clinton Bybee	4.5%	4,550,630
Robert Nelsen	4.6%	4,600,747
Vanguard Group Inc 13G/A	0%	0	13G/A	3/26/2026 Event 3/13/2026

13F Holders by Quarter

Period	Filers	Shares, Excl. Options	Value, Excl. Options	Options Value
2026 Q3	96	10.6 M	$258M	$1.17M
2026 Q2	279	113 M	$4.20B	$26.9M
2026 Q1	256	108 M	$2.58B	$21.1M
2025 Q4	249	107 M	$2.96B	$73.2M
2025 Q3	227	107 M	$2.60B	$37.6M
2025 Q2	220	109 M	$1.85B	$47.0M
2025 Q1	239	101 M	$1.99B	$14.3M
2024 Q4	236	81.5 M	$2.02B	$9.38M
2024 Q3	224	79.7 M	$1.95B	$16.4M
2024 Q2	217	79.1 M	$1.85B	$11.4M
2024 Q1	227	79.1 M	$2.61B	$35.9M
2023 Q4	191	74.1 M	$2.02B	$13.2M
2023 Q3	201	67.4 M	$1.62B	$17.1M
2023 Q2	198	64.2 M	$2.05B	$19.3M
2023 Q1	212	66.5 M	$2.04B	$25.3M
2022 Q4	214	59.0 M	$2.31B	$22.5M
2022 Q3	229	54.7 M	$2.60B	$46.2M
2022 Q2	207	54.8 M	$2.09B	$19.0M
2022 Q1	244	49.2 M	$2.82B	$41.0M
2021 Q4	235	45.6 M	$3.64B	$49.8M
2021 Q3	233	45.2 M	$3.93B	$42.5M
2021 Q2	240	46.2 M	$5.93B	$86.4M
2021 Q1	217	43.6 M	$3.47B	$109M
2020 Q4	160	37.0 M	$3.02B	$56.9M
2020 Q3	85	29.5 M	$727M	$0
2020 Q2	72	27.7 M	$776M	$0
2020 Q1	61	27.2 M	$489M	$0